Evexia Diagnostics now offers 20/20 BioLabs’ OneTest™ MCED test, giving clinicians affordable, biomarker insights for early cancer detection and care. WASHINGTON, CT, UNITED STATES, April 7, 2026 / EINPresswire.com / -- Evexia Diagnostics, a leading provider of comprehensive clinical laboratory services to integrative, functional, and preventive medicine practitioners throughout the U.S., is pleased to announce that its clients can now access 20/20 BioLabs (Nasdaq: AIDX) OneTest™ for Cancer, a

Diabetes patients in Medicare spent significantly less on insulin in the first year after a $35 monthly cap was put in place in 2023 — and more of them appeared to adhere to treatment. A new study published Monday in JAMA Internal Medicine looked at medical records from 4.8 million type 2 diabetes patients before and after the cap took effect. The results provide early evidence that the new pricing policy, enacted under the Inflation Reduction Act, may be linked to increased access to insulin. “

Documented results show measurable reading gains when instruction follows the brain’s developmental sequence—challenging common assumptions about dyslexia It wasn’t just a struggle with reading—it was a struggle with living. Now she’s able to live like her peers.” — Eshanne, parent of the student JACKSONVILLE, FL, UNITED STATES, April 7, 2026 / EINPresswire.com / -- Key Takeaways ● Case study: 13-year-old homeschooled student progressed from non-reader to 12th-grade reading accuracy in under 10

MEMPHIS, Tenn. and AUSTIN, Texas, April 7, 2026 /PRNewswire/ -- West Cancer Center & Research Institute, the Mid‑South's premier provider of comprehensive adult cancer care, and IDEOlogy Health, a leader in delivering non‑promotional, multi‑channel medical education to oncology professionals, today announced two exclusive strategic partnership agreements designed to elevate physician and Advanced Practice Provider (APP) education. Together, these collaborations aim to strengthen oncology care

ORLANDO, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is proud to announce the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market. NexTel will begin the distribution of test kits this week to initiate the collection of essential control samples. These samples serve as the foundati

Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company EQT Life Sciences led the Series B2 financing of Tubulis in March 2024, and has since suppEQTorted the Company at board level in its growth to a leading global clinical-stage ADC company AMSTERDAM, April 7, 2026 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund ("EQT Life Sciences") has exited its minority stake in Tubulis (the "Comp

HOUSTON, TX, UNITED STATES, April 7, 2026 / EINPresswire.com / -- HeartLung AI today welcomed CMS’s establishment of HCPCS code G0680 in the April 2026 Hospital Outpatient Prospective Payment System update, effective April 1, 2026, for algorithmic analysis of coronary artery calcium (CAC) and/or aortic valve calcification from chest CT with report. By assigning G0680 status indicator S and APC 1492, CMS has created a reimbursement pathway in the hospital outpatient setting for AI-enabled opportu

Collaboration builds on CAR-T commercialization in New Zealand and supports expansion across Australia, North America and other international marketsWELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE NEWSWIRE) -- BioOra Limited ("BioOra"), a commercial-stage cell therapy company advancing CAR-T therapies for cancer patients, and Octane Biotech Inc., an Octane Medical Group Company ("Octane"), today announced the signing of a Letter of Intent (LOI) to collaborate on the co-dev

The White House this week began offering a $950-per-month version of AbbVie’s megablockbuster Humira on TrumpRx, even as the drug discount website also offers two Humira biosimilars from Pfizer and Amgen that both cost less than $300 per month. It remains unclear who would purchase brand-name Humira through TrumpRx. The cash-pay government website doesn’t accept insurance, and those on Humira with coverage can pay as little as $5. Those on Medicare have seen their out-of-pocket expenses capped a

The publication will provide a platform to share discoveries and advance knowledge across the field of pediatric and AYA oncology ATLANTA, April 7, 2026 /PRNewswire/ -- The American Cancer Society (ACS) today announced the launch of its fourth medical journal, Pediatric, Adolescent & Young Adult Cancer. This international, multidisciplinary publication will feature peer-reviewed original research and solicited content on the latest advances in cancers affecting children, adolescents, and young a